Overview
Hans Dieplinger practices in Innsbruck, Austria. Mr. Dieplinger is highly rated in 4 conditions, according to our data. His top areas of expertise are High Cholesterol, Metabolic Syndrome, Familial Hypercholesterolemia, and Defective Apolipoprotein B-100.
His clinical research consists of co-authoring 39 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Defective Apolipoprotein B-100Mr. Dieplinger isAdvanced. Learn about Defective Apolipoprotein B-100.
- Familial HypercholesterolemiaMr. Dieplinger isAdvanced. Learn about Familial Hypercholesterolemia.
- High CholesterolMr. Dieplinger isAdvanced. Learn about High Cholesterol.
- Metabolic SyndromeMr. Dieplinger isAdvanced. Learn about Metabolic Syndrome.
- Experienced
- Abdominal Obesity Metabolic SyndromeMr. Dieplinger isExperienced. Learn about Abdominal Obesity Metabolic Syndrome.
- AtherosclerosisMr. Dieplinger isExperienced. Learn about Atherosclerosis.
- Gestational DiabetesMr. Dieplinger isExperienced. Learn about Gestational Diabetes.
- Heterozygous Familial Hypercholesterolemia (HeFH)
- Homozygous Familial Hypercholesterolemia (HoFH)Mr. Dieplinger isExperienced. Learn about Homozygous Familial Hypercholesterolemia (HoFH).
- Non-Alcoholic Fatty Liver DiseaseMr. Dieplinger isExperienced. Learn about Non-Alcoholic Fatty Liver Disease.